Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05571774
Other study ID # SOOCHOW-HY-2022-12
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 20, 2022
Est. completion date October 20, 2028

Study information

Verified date September 2022
Source The First Affiliated Hospital of Soochow University
Contact Yue Han, Ph.D
Phone +86 18913091817
Email hanyue@suda.edu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Oct 20, 2022, to Oct 20, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical related data of thrombotic thrombocytopenic purpura.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date October 20, 2028
Est. primary completion date October 20, 2027
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Subjects diagnosed with severe ADAMTS13 deficiency, defined as ADAMTS13 activity <10%, documented in the patient's medical history or at screening. Exclusion Criteria: - The investigator considers the subject unable or unwilling to cooperate with the study procedures.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
collection data
collection data

Locations

Country Name City State
China the first affiliated hospital of Soochow university Suzhou Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
The First Affiliated Hospital of Soochow University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants with stroke Stroke was assessed with MRI imaging. 5 years from the time of entering the database.
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06376786 - Italian iTTP Registry
Recruiting NCT03832881 - The United Kingdom Thrombotic Thrombocytopenic Purpura Registry (UK TTP Registry)
Recruiting NCT05950750 - Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study